Market Research Logo

Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016

Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Integrated BioTherapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Integrated BioTherapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Integrated BioTherapeutics, Inc.
The report provides overview of Integrated BioTherapeutics, Inc. including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Integrated BioTherapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Integrated BioTherapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Integrated BioTherapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Integrated BioTherapeutics, Inc.
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Integrated BioTherapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
Integrated BioTherapeutics, Inc. Snapshot
Integrated BioTherapeutics, Inc. Overview
Key Information
Key Facts
Integrated BioTherapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Integrated BioTherapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Integrated BioTherapeutics, Inc. - Pipeline Products Glance
Integrated BioTherapeutics, Inc. - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Integrated BioTherapeutics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Integrated BioTherapeutics, Inc. - Drug Profiles
STEBVax
Product Description
Mechanism of Action
R&D Progress
(Ebola + Marburg) vaccine
Product Description
Mechanism of Action
R&D Progress
Antibodies for Ebola and Marburg Viral Infections
Product Description
Mechanism of Action
R&D Progress
AT-62aa
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies for Ebola and Marburg Infections
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies for Equine Encephalitis and Chikungunya
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies to Inhibit E2 Glycoprotein for HCV
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody 1 for Staphylococcus Aureus Infections
Product Description
Mechanism of Action
R&D Progress
Integrated BioTherapeutics, Inc. - Pipeline Analysis
Integrated BioTherapeutics, Inc. - Pipeline Products by Target
Integrated BioTherapeutics, Inc. - Pipeline Products by Route of Administration
Integrated BioTherapeutics, Inc. - Pipeline Products by Molecule Type
Integrated BioTherapeutics, Inc. - Pipeline Products by Mechanism of Action
Integrated BioTherapeutics, Inc. - Recent Pipeline Updates
Integrated BioTherapeutics, Inc. - Dormant Projects
Integrated BioTherapeutics, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Integrated BioTherapeutics, Inc., Key Information
Integrated BioTherapeutics, Inc., Key Facts
Integrated BioTherapeutics, Inc. - Pipeline by Indication, 2016
Integrated BioTherapeutics, Inc. - Pipeline by Stage of Development, 2016
Integrated BioTherapeutics, Inc. - Monotherapy Products in Pipeline, 2016
Integrated BioTherapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016
Integrated BioTherapeutics, Inc. - Phase I, 2016
Integrated BioTherapeutics, Inc. - Preclinical, 2016
Integrated BioTherapeutics, Inc. - Discovery, 2016
Integrated BioTherapeutics, Inc. - Pipeline by Target, 2016
Integrated BioTherapeutics, Inc. - Pipeline by Route of Administration, 2016
Integrated BioTherapeutics, Inc. - Pipeline by Molecule Type, 2016
Integrated BioTherapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016
Integrated BioTherapeutics, Inc. - Recent Pipeline Updates, 2016
Integrated BioTherapeutics, Inc. - Dormant Developmental Projects,2016
List of Figures
Integrated BioTherapeutics, Inc. - Pipeline by Indication, 2016
Integrated BioTherapeutics, Inc. - Pipeline by Stage of Development, 2016
Integrated BioTherapeutics, Inc. - Monotherapy Products in Pipeline, 2016
Integrated BioTherapeutics, Inc. - Pipeline by Target, 2016
Integrated BioTherapeutics, Inc. - Pipeline by Molecule Type, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report